FDA approves efficacy supplement for UCB's Zilbrysq
The agency cleared supplement 15 for the zilucoplan sodium injection, according to an FDA drug approval letter dated October 19, 2026.
Drugs@FDA
1 story
The agency cleared supplement 15 for the zilucoplan sodium injection, according to an FDA drug approval letter dated October 19, 2026.
Drugs@FDA